ZGNX seems to be helping not hurting as above avg vol & price action yesterday. Reading through the comments overwhelmingly positive to have a safer Hydrocodone product in extended release & APAP free which would eliminate liver toxicity... Even more so some realize the dollar potential of Zohydro Oppenhiemer pegs it around 500 million a year for Zohydro coupled with their migraine drug still growing sales would easily be a $10 to $15 stock. Then throw out there the next Oxycontin & some see $$$$ signs....imo only FDA needs & wants an Acetaminophen free Hydrocodone as they almost eliminated the entire Hydrodone class